Genetic Findings in a Cohort of Patients with Androgen Insensitivity Syndrome

Wencui Wang,Sichang Zheng,Yu Zhao,Zhihan Wan,Rulai Han,Yan Qi,Guang Ning,Shouyue Sun,Lei Ye,Weiqing Wang
DOI: https://doi.org/10.21203/rs.3.rs-499273/v1
2021-01-01
Abstract:Abstract Background: Androgen insensitivity syndrome (AIS) is a rare X-linked recessive inherited disorder caused by mutations in AR, a gene encoding androgen receptor. The aim of this study was to expand genetic spectrum of AIS.Methods: We performed a retrospective study on consecutive patients diagnosed as AIS from 2010 to 2020 in a single tertiary center. Variant analysis of AR gene was performed by PCR-Sanger sequencing. The pathogenicity of novel variants was evaluated by dual-luciferase reporter assay and immunofluorescence of AR protein in vitro. Results: A total of 19 unrelated 46,XY patients were enrolled, 14 with complete insensitivity syndrome (CAIS) and 5 with partial insensitivity syndrome (PAIS). We identified 19 AR variants: 12 (63.2%) were missense variants and 7 variants (36.8%) resulted in premature stop codon. Eight AR variants were novel, including P15Afs*69, S258Efs*47, W435Gfs*44, C560F, C577W, C580Afs*46, K718X and V819G. Dual-luciferase reporter assay found residual transcription activity of approximately 1% in six novel variants, which may explain the CAIS phenotype. The AR mutant protein (V819G) showed transcription activity of 59%, consistent with mild clinical features in one PAIS patient. Interestingly, another AR mutant protein (K718X) related to CAIS showed increased transcription activity but impaired nuclear localization. Conclusions: We identified eight novel AR variants related to AIS. Both residual transcription activity of AR and nuclear localization of AR protein were associated with the severity of AIS.
What problem does this paper attempt to address?